Is NF-κB2/p100 a direct activator of programmed cell death?

Cancer Cell

Volumn 2, Issue 6, 2002, Pages 431-433

  Häcker, Hans ^a   Karin, Michael ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 2; LYMPHOTOXIN BETA; PROTEIN P100; PROTEIN P52; PROTEIN S100B; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SND1 PROTEIN, HUMAN;

APOPTOSIS; B LYMPHOCYTE ACTIVATION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DEATH; CELL ISOLATION; GROWTH REGULATION; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION TERMINATION; UBIQUITINATION; ANIMAL; CELL TRANSFORMATION; GENETICS; HUMAN; MUTATION; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LYMPHOMA; MUTATION; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 0037498747     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00213-1     Document Type: Review

References (18)

1. Claudio, E., Brown, K., Park, S., Wang, H., and Siebenlist, U. (2002). Nat. Immunol. 3, 958-965.
2. Dejardin, E., Droin, N.M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z.W., Karin, M., Ware, C.F., and Green, D.R. (2002). Immunity 17, 525-535.
3. Fong, A., Zhang, M., Neely, J., and Sun, S.C. (2002). J. Biol. Chem. 277, 40697-40702.
4. Franzoso, G., Carlson, L., Poljak, L., Shores, E.W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., et al. (1998). J. Exp. Med. 187, 147-159.
5. Ghosh, S., and Karin, M. (2002). Cell 109 (Suppl), S81-96.
6. Hofmann, K. (1999). Cell. Mol. Life Sci. 55, 1113-1128.
7. Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.P., and Bravo, R. (1997). J. Exp. Med. 186, 999-1014.
8. Karin, M., Cao, Y., Greten, F.R., and Li, Z.W. (2002). Nat. Rev. Cancer 2, 301-310.
9. Kumar, S., and Vaux, D.L. (2002). Science 297, 1290-1291.
10. Lassus, P., Opitz-Araya, X., and Lazebnik, Y. (2002). Science 297, 1352-1354.
11. Mercurio, F., DiDonato, J.A., Rosette, C., and Karin, M. (1993). Genes Dev. 7, 705-718.
12. Migliazza, A., Lombardi, L., Rocchi, M., Trecca, D., Chang, C.C., Antonacci, R., Fracchiolla, N.S., Ciana, P., Maiolo, A.T., and Neri, A. (1994). Blood 84, 3850-3860.
13. Miosge, L.A., Blasioli, J., Blery, M., and Goodnow, C.C. (2002). J. Exp. Med. 196, 1113-1119.
14. Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. (1998). Nature 395, 297-300.
15. Salvesen, G.S., and Dixit, V.M. (1999). Proc. Natl. Acad. Sci. USA 96, 10964-10967.
16. Senftleben, U., Cao, Y., Xiao, G., Greten, F.R., Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.C., and Karin, M. (2001). Science 293, 1495-1499.
17. Wang, Y., Cui, H., Schroering, A., Ding, J.L., Lane, W.S., McGill, G., Fisher, D.E., and Ding, H.F. (2002). Nat. Cell Biol. 4, 888-893.
18. Xiao, G., Harhaj, E.W., and Sun, S.C. (2001). Mol. Cell 7, 401-409.